You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-873-ESGO Validation study of the ‘NOGGO-GIS ASSAY’ based on ovarian cancer samples from the first-line PAOLA-1/ENGOT-ov25 phase-III trial

Article metrics

Article menu

Download PDFPDF

Pathology
2022-RA-873-ESGO Validation study of the ‘NOGGO-GIS ASSAY’ based on ovarian cancer samples from the first-line PAOLA-1/ENGOT-ov25 phase-III trial
Free

 

Online download statistics by month:

Online download statistics by month: October 2022 to March 2023

AbstractFullPdf
Oct 202281020
Nov 2022137023
Dec 202297024
Jan 2023150014
Feb 20237206
Mar 202395019
Total6320106